The relation between staging fluorine-18 fluorodeoxyglucose positron emission tomog- raphy/computed tomography metabolic parameters and tumor necrosis rate in pediatric osteosarcoma patients
Open Access
- 28 June 2021
- journal article
- research article
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (3) , 1115-1122
Abstract
The aim of this study was to investigate the contribution of fluorine-18 (F-18) fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) imaging in staging of pediatric osteosarcoma patients and also to evaluate the ability of metabolic parameters from the primary tumor to predict tumor necrosis rate (TNR). F-18 FDG-PET/CT imaging was performed in staging 37 pediatric osteosarcoma patients. The metabolic parameters SUVmax (maximum standardised uptake value), MTV (metabolic tumour volume) and TLG (total lesion glycolysis) were measured from the primary tumor. TNR level of the primary tumor was histopathologically measured after standard neoadjuvant chemotherapy treatment. The contribution of F-18 FDG-PET/CT to staging of pediatric osteosarcoma patients and the accuracy of metabolic parameters of the primary tumor to predict TNR were analized by regression analysis. MTV and TLG of the primary tumor were found to efficiently predict histopathologic TNR, whereas SUVmax was not (p=0.012, p=0.027, p=0.25, respectively). Also 5 of 12 patients (41.6%) who were initially defined as localised osteosarcoma were upstaged in consequence of staging F-18 FDG-PET/CT findings. F-18 FDG-PET/CT staging in pediatric osteosarcoma patients can effectively distinguish metastatic-localised disease. MTV and TLG values are important parameters which can efficiently be used to predict TNR.Keywords
This publication has 19 references indexed in Scilit:
- Comparison of (18)F-FDG PET/CT and (99 m)Tc-MDP bone scintigraphy for detection of bone metastasis in osteosarcomaSkeletal Radiology, 2013
- The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcomaRadiology and Oncology, 2013
- Outcome for adolescent and young adult patients with osteosarcomaCancer, 2012
- Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trialsAnnals of Oncology, 2011
- Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- 18F-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in OsteosarcomaJournal of Nuclear Medicine, 2009
- Positron Emission Tomography for Staging of Pediatric Sarcoma Patients: Results of a Prospective Multicenter TrialJournal of Clinical Oncology, 2007
- SFOP OS94: A randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patientsEuropean Journal of Cancer, 2007
- Treatment Effects in Pediatric Soft Tissue and Bone TumorsAmerican Journal of Clinical Pathology, 2005
- Evaluation of chemotherapy response in pediatric bone sarcomas by [F‐18]‐fluorodeoxy‐D‐glucose positron emission tomographyCancer, 2002